Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01558544 · ClinicalTrials.gov registry record · NA

Cryopreservation of Ovarian Tissue

A NA study of Cancer and Fertility Preservation, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT01558544: Recruiting NA study of Cancer and Fertility Preservation, sponsored by Weill Medical College of Cornell University.

NCT01558544 is a NA study of Cancer and Fertility Preservation that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 300 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01558544, a NA study of Cancer and Fertility Preservation, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

Primary Outcome

Ovarian tissue cryopreservation Survival of tissue undergoing cryopreservation, thawing and maturation of immature eggs.

Interventions

  • PROCEDURE surgery to remove ovaries or high dose chemotherapy

Study Locations (1)

New York

  • Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine - New York

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 1997-04
Est. Completion 2029-10-31
Phase NA

What NCT01558544 shows while recruiting

NCT01558544 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (91% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which surgery to remove ovaries or high dose chemotherapy is the first listed.

NCT01558544 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT01558544 about?

NCT01558544 is a clinical study titled "Cryopreservation of Ovarian Tissue". The study hopes to contribute to the development of technologies of ovarian tissue freezing-thawing and in vitro maturation of immature eggs such that a person at risk for premature ovarian failure might be able to conceive a genetically related child.

What is the current status of trial NCT01558544?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 1997-04. Estimated completion is 2029-10-31.

What conditions does trial NCT01558544 study?

This clinical trial studies the following conditions: Cancer, Fertility Preservation, Risk of Premature Ovarian Failure.

What interventions are being tested in trial NCT01558544?

The interventions under investigation include: surgery to remove ovaries or high dose chemotherapy (PROCEDURE).

Who is sponsoring clinical trial NCT01558544?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01558544 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01558544's enrollment target sits among peer trials

300 179th of 615 higher than 428 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01558544, the US trial registry maintained by the National Library of Medicine. NCT01558544 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.